Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Drugs & Aging
Erschienen in: Drugs & Aging 7/2016

23.05.2016 | Review Article

Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices

verfasst von: Federico Lavorini, Claudia Mannini, Elisa Chellini, Giovanni A. Fontana

Erschienen in: Drugs & Aging | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Chronic obstructive pulmonary disease (COPD) is common in older people. Inhaled medications are the mainstay of pharmacological treatment of COPD, and are typically administered by handheld inhalers, such as pressurised metered-dose inhalers and dry powder inhalers, or by nebulisers. For each of the three major categories of aerosol delivery devices, several new inhalers have recently been launched, each with their own particularities, advantages and disadvantages. Consequently, broader availability of new drug–device combinations will increase prescription opportunities. Despite this, however, there is limited guidance available in published guidelines on the choice of inhalers, and still less consideration is given to elderly patients with COPD. The aim of this article is to provide a guide for healthcare professionals on device selection and factors to be considered for effective inhaled drug delivery in elderly COPD patients, including device factors (device type and complexity of use), patient factors (inspiratory capabilities, manual dexterity and hand strength, cognitive ability, co-morbidities) and considerations for healthcare professionals (proper education of patients in device use).
Literatur
1.
Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5 Suppl):121s–6s.CrossRefPubMed
2.
Murray CJ. Lopez AD Alternative projections of mortality, disability by cause 1990–2020. Global Burden of Disease Study. Lancet. 1997;349:1498–504.CrossRefPubMed
3.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. GOLD. http://​www.​goldcopd.​org. Accessed 7 May 2016.
4.
Pistolesi M, Camiciottoli G, Paoletti M, Marmai C, Lavorini F, Meoni E, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med. 2008;102:367–76.CrossRefPubMed
5.
Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127:335–71.CrossRefPubMed
6.
Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003;16:249–54.CrossRefPubMed
7.
Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med. 2006;100:1479–94.CrossRefPubMed
8.
Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102:593–604.CrossRefPubMed
9.
Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med Res. 2011;105:930–8.CrossRef
10.
Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among aged 18 and over in the United States, 1998-2009. NCHS Data Brief. 2011;63:1–8.PubMed
11.
Janssens JP. Aging of the respiratory system: impact on pulmonary function tests sand adaptation to exertion. Clin Chest Med. 2005;26:469–72.CrossRefPubMed
12.
Allen SC. Competence thresholds for the use of inhalers in people with dementia. Age Ageing. 1997;26:83–6.CrossRefPubMed
13.
Dalby R, Spallek M, Voshaar T. A review of the development of Respimat soft mist inhaler. Int J Pharm. 2004;283:1–9.CrossRefPubMed
14.
Lavorini F, Fontana GA, Usmani OS. New inhaler devices—the good, the bad and the ugly. Respiration. 2014;88:3–15.CrossRefPubMed
15.
Leach CL. The CFC to HFA transition and its impact on pulmonary drug development. Respir Care. 2005;50:1201–8.PubMed
16.
Fink JB. Metered-dose inhalers, dry powder inhalers, and transitions. Respir Care. 2000;45:623–35.PubMed
17.
Hendeles L, Colice GL, Meyer RJ. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med. 2007;356:1344–51.CrossRefPubMed
18.
Acerbi D, Brambilla G, Kottakis I. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm Pharmacol Ther. 2007;20:290–303.CrossRefPubMed
19.
Dhillon S, Keating GM. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. Drugs. 2006;66:1475–83.CrossRefPubMed
20.
Laube BL, Janssens HM, de Jongh FHC, Devadason SG, Dhand R, Diot P, et al. European Respiratory Society; International Society for Aerosols in Medicine. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308–31.CrossRefPubMed
21.
Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5:1–149.CrossRefPubMed
22.
Lavorini F, Fontana GA. Targeting drugs to the lungs: effect of spacer device. Exp Opin Drug Deliv. 2009;6:91–102.CrossRef
23.
Sadowski CA, Cor K, Cave A, Banh HL. Administration technique and acceptance of inhaler devices in patients with asthma and COPD. Ann Pharmacother. 2015;49:639–48.CrossRefPubMed
24.
Newman SP, Weisz A, Talaee N, Clarke S. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax. 1991;46:712–6.CrossRefPubMedPubMedCentral
25.
Price DB, Pearce L, Powell SR, Shirley J, Sayers MK. Handling and acceptability of the Easi-breathe device compared with a conventional metered dose inhaler by patients and practice nurses. Int J Clin Pract. 1999;53:31–6.PubMed
26.
Hampson NB, Mueller MP. Reduction in patient timing errors using a breath-activated metered dose inhaler. Chest. 1994;106:462–5.CrossRefPubMed
27.
Lenny J, Innes J, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med. 2000;94:496–500.CrossRef
28.
Smith IJ, Bell J, Bowman N, Everard M, Stein S, Weers JG. Inhaler devices: what remains to be done? J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 2):s25–37.PubMed
29.
Chrystyn H, Small M, Milligan G, Higgins V, Gil EG, Estruch J. Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108:358–65.CrossRefPubMed
30.
Azouz W, Chrystyn H. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim Care Respir J. 2012;21:208–13.CrossRefPubMed
31.
de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW. Can ‘extrafine’ dry powder aerosols improve lung deposition? Eur J Pharm Biopharm. 2015;96:143–51.CrossRefPubMed
32.
Pavkov R, Mueller S, Fiebich K, Singh D, Stowasser F, Pignatelli G. Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol G. Curr Med Res Opin. 2010;26:2527–33.CrossRefPubMed
33.
Buttini F, Brambilla G, Copelli D, Sisti V, Balducci AG, Bettini R, et al. Effect of flow rate on in vitro aerodynamic performance of NEXThaler® in comparison with Diskus® and Turbohaler® dry powder inhalers. J Aerosol Med Pulm Drug Deliv. 2016;29:167–78.CrossRefPubMedPubMedCentral
34.
Capstick TG, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med. 2012;6:91–101.CrossRefPubMed
35.
Grant AC, Walker R, Hamilton M, Garrill K. The ELLIPTA® dry powder inhaler: design, functionality, in vitro dosing performance and critical task compliance by patients and caregivers. J Aerosol Med Pulm Drug Deliv. 2015;28:474–85.CrossRefPubMedPubMedCentral
36.
Lavorini F, Levy ML, Corrigan C, Crompton G, ADMIT Working Group. The ADMIT series—issues in inhalation therapy. 6) Training tools for inhalation devices. Prim Care Respir Med. 2010;19:335–41.
37.
Newman S. Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery. Expert Opin Drug Deliv. 2014;11:365–78.CrossRefPubMed
38.
39.
Hess DR. Nebulizers: principles and performance. Respir Care. 2000;45:609–22.PubMed
40.
Boe J, Dennis JH, O’Driscoll BR, Bauer TT, Carone M, Dautzenberg B, et al. European Respiratory Society guidelines on the use of nebulizers. Eur Respir J. 2001;18:228–42.CrossRefPubMed
41.
Hess DR, Fisher D, Williams P, Pooler S, Kacmarek RM. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest. 1996;110:498–505.CrossRefPubMed
42.
Dhand R. Nebulisers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care. 2002;47:1406–16.PubMed
43.
Nikander K. Adaptive aerosol delivery: the principles. Eur Respir Rev. 1999;7:385–7.CrossRef
44.
Denyer J. Adaptive aerosol delivery in practice. Eur Respir Rev. 1997;7:388–9.
45.
Waldrep JC, Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv. 2008;5:114–9.CrossRefPubMed
46.
Skaria S, Smaldone GC. Omron NE U22: comparison between vibrating mesh and jet nebulizer. J Aerosol Med Pulm Drug Deliv. 2010;23:173–80.CrossRefPubMed
47.
Geller DE. Comparing clinical features of nebulizer, metered-dose inhaler, and dry powder inhaler. Respir Care. 2005;50:1313–21.PubMed
48.
Balzano G, Battiloro R, Biraghi M. Effectiveness and acceptability of domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. J Aerosol Med. 2000;13:25–33.CrossRefPubMed
49.
Barta SK, Crawford A, Roberts CM. Survey of patients’ views of domiciliary nebuliser treatment for chronic lung disease. Respir Med. 2002;96:375–81.CrossRefPubMed
50.
Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet. 2011;377:1032–45.CrossRefPubMed
51.
O’Donohue WJ, National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Group. Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. Chest. 1996;109:814–20.CrossRefPubMed
52.
Kassner F, Hodder R, Bateman ED. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat soft mist inhaler in patients with asthma and chronic obstructive pulmonary disease. Drugs. 2004;64:1671–82.CrossRefPubMed
53.
Roche N, Reddel HK, Agusti A, Bateman ED, Krishnan JA, Martin RJ, et al. Respiratory Effectiveness Group. Integrating real-life studies in the global therapeutic research framework. Lancet. Respir Med. 2013;1:e29–30.
54.
Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;20(11):CD000011.
55.
Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:371–84.PubMedPubMedCentral
56.
Ingebrigtsen TS, Marott JL, Nordestgaard BG, Lange P, Hallas J, Dahl M, et al. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2015;30:51–9.CrossRefPubMed
57.
Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2012;52:275–301.CrossRefPubMed
58.
Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64:939–43.CrossRefPubMed
59.
Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.CrossRefPubMedPubMedCentral
60.
Coventry PA, Fisher L, Kenning C, Bee P, Bower P. Capacity, responsibility, and motivation: a critical qualitative evaluation of patient and practitioner views about barriers to self-management in people with multimorbidity. BMC Health Serv Res. 2014;14:536.CrossRefPubMedPubMedCentral
61.
Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000;55:68–78.CrossRefPubMed
62.
Patel M, Perrin K, Pritchard A, Williams M, Wijesinghe M, Weatherall M, et al. Accuracy of patient self-report as a measure of inhaled asthma medication use. Respirology. 2013;18:546–52.CrossRefPubMed
63.
Chan AH, Reddel HK, Apter A, Eakin M, Riekert K, Foster JM. Adherence monitoring and e-health: how clinicians and researchers can use technology to promote inhaler adherence for asthma. J Allergy Clin Immunol Pract. 2013;1:446–54.CrossRefPubMed
64.
Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19:696–704.CrossRefPubMedPubMedCentral
65.
Pritchard JN, Nicholls C. Emerging technologies for electronic monitoring of adherence, inhaler competence, and true adherence. J Aerosol Med Pulm Durg Deliv. 2015;28:69–81.CrossRef
66.
Williamson SS, Gorman PN, Jimison HB. A mobile/web app for long distance caregivers of older adults: functional requirements and design implications from a user centered design process. AMIA Annu Symp Proc. 2014;2014:1960–9.PubMedPubMedCentral
67.
Boulos MN, Brewer AC, Karinmkhani C, Buller DB, Dellavalle RP. Mobile medical and health apps: state of the art, concerns, regulatory control and certification. Online J Public Health Inform. 2014;5:229.PubMedPubMedCentral
68.
Wieshammer S, Dreyhaupt J. Dry powder inhalers: which factors determine the frequency of handling errors? Respiration. 2008;75:18–25.CrossRefPubMed
69.
Barros G, Pegram A, Borries A. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease. Am J Health-Syst Pharm. 2011;68:1221–32.CrossRef
70.
Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186:240–5.CrossRefPubMed
71.
Reijnders J, van Heugten C, van Boxtel M. Cognitive interventions in healthy older adults and people with mild cognitive impairment: a systematic review. Ageing Res Rev. 2013;12:263–75.CrossRefPubMed
72.
73.
Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142:1516–23.CrossRefPubMed
74.
75.
Gray SL, Williams DM, Pulliam CC, Sirgo MA, Bishop AL, Donohue JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med. 1996;156:984–8.CrossRefPubMed
76.
Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J. Guidance on handheld inhalers in asthma and COPD guidelines. Respir Med. 2014;108:694–700.CrossRefPubMed
77.
Lavorini F. Inhaled drug delivery in the hands of the patient. J Aerosol Med Pulm Drug Deliv. 2014;27:414–8.CrossRefPubMed
78.
Dekhuijzen PN, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, et al. Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach. Respir Med. 2013;107:1817–21.CrossRefPubMed
79.
Vinken W, Dekhuijzen R, Barnes PJ, on behalf of the ADMIT Group. The ADMIT series—issues in inhalation therapy. How to choose inhaler devices for the treatment of COPD. Prim Care Respir J. 2010;19:10–20.CrossRef
80.
Lavorini F, Fontana GA. Inhaler technique and patient’s preference for dry powder inhaler devices. Expert Opin Drug Deliv. 2014;11:1–3.CrossRefPubMed
81.
Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J. 2015;8:26.CrossRefPubMedPubMedCentral
82.
Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med. 2000;94:496–500.CrossRefPubMed
83.
Molimard M, Colthorpe P. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. J Aerosol Med Pulm Drug Deliv. 2015;28:219–28.CrossRefPubMedPubMedCentral
84.
Chapman KR, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest. 1993;104:1332–7.CrossRefPubMed
85.
Ho SF, Ms OM, Steward JA, Breay P, Burr ML. Inhaler technique in older people in the community. Age Ageing. 2004;33:185–8.CrossRefPubMed
86.
Poole PJ, Saini R, Brodie SM, Black PN. Comparison of the effects of nebulized and inhaled salbutamol on breathlessness in severe COPD. Respir Med. 2005;99:372–6.CrossRefPubMed
87.
Berry RB, Shinto RA, Wong FH, Despars JA, Light RW. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD. Chest. 1989;96:1241–6.CrossRefPubMed
88.
van der Palen J, Klein JJ, Kerkhoff AH, van Herwaarden CL. Evaluation of the effectiveness of 4 different inhalers in patients with COPD. Thorax. 1995;50:1183–7.CrossRefPubMedPubMedCentral
89.
Jones V, Fernandez C, Diggory P. A comparison of large volume spacer, breath-activated and dry powder inhalers in older people. Age Ageing. 1999;28:481–4.CrossRefPubMed
90.
Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50:1360–74.PubMed
91.
Sestini P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, Associazione Italiana Pneumologi Ospedalieri Educational Group, et al. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med. 2006;19:127–36.CrossRefPubMed
92.
Göriş S, Taşci S, Elmali F. The effects of training on inhaler technique and quality of life in patients with COPD. J Aerosol Med Pulm Drug Deliv. 2013;26:336–44.CrossRefPubMed
93.
Jolly GP, Mohan A, Guleria R, Poulose R, George J. Evaluation of metered dose inhaler use technique and response to educational training. Indian J Chest Dis Allied Sci. 2015;57:17–20.PubMed
94.
Self TH, Arnold LB, Czosnowski LM, Swanson JM, Swanson H. Inadequate skill of healthcare professionals in using asthma inhalation devices. J Asthma. 2007;44:593–8.CrossRefPubMed
95.
Casset A, Meunier-Spitz M, Rebotier P, Lefèvre H, Barth C, Heitz C, et al. Asthma management and inhalation techniques among community pharmacists in 2009: a comparison with the 1999 survey. J Asthma. 2014;51:964–73.CrossRefPubMed
96.
Gemicioglu B, Borekci S, Can G. Investigation of knowledge of asthma and inhaler devices in pharmacy workers. J Asthma. 2014;51:982–8.CrossRefPubMed
97.
Basheti IA, Qunaibi EA, Hamadi SA, Reddel HK. Inhaler technique training and health-care professionals: effective long-term solution for a current problem. Respir Care. 2014;59:1716–25.CrossRefPubMed
98.
De Tratto K, Gomez C, Ryan CJ, Bracken N, Steffen A, Corbridge SJ. Nurses’ knowledge of inhaler technique in the inpatient hospital setting. Clin Nurse Spec. 2014;28:156–60.CrossRefPubMed
99.
Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel’s knowledge of and ability to use inhaling devices—metered-dose inhalers, spacing chambers, and breath-actuated powder inhalers. Chest. 1994;105:111–6.CrossRefPubMed
100.
Kim SH, Kwak HJ, Kim TB, Chang YS, Jeong JW, Kim CW, et al. Inappropriate techniques used by internal medicine residents with three kinds of inhalers (a metered dose inhaler, Diskus, and Turbuhaler): changes after a single teaching session. J Asthma. 2009;46:944–95.CrossRefPubMed
101.
Leung J, Bhutani M, Leigh R, Pelletier D, Good C, Sin DD. Empowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthma. Can Respir J. 2015;22:266–70.CrossRefPubMedPubMedCentral
Metadaten
Titel
Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices
verfasst von
Federico Lavorini
Claudia Mannini
Elisa Chellini
Giovanni A. Fontana
Publikationsdatum
23.05.2016
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 7/2016
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-016-0377-y

Weitere Artikel der Ausgabe 7/2016

Drugs & Aging 7/2016 Zur Ausgabe

Therapy in Practice

Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine

Original Research Article

Changing Pattern of Sedative Use in Older Adults: A Population-Based Cohort Study

Systematic Review

Association Between Non-Steroidal Anti-Inflammatory Drug Use and Cognitive Decline: A Systematic Review and Meta-Analysis of Prospective Cohort Studies

Original Research Article

Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies

Review Article

Drug Treatment of Venous Thromboembolism in the Elderly

Review Article

Minimizing the Risk of Bleeding with NOACs in the Elderly

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Metformin rückt in den Hintergrund

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

24.04.2024 | DGIM 2024 | Nachrichten

Bei Senioren mit Prostatakarzinom auf Anämie achten!
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise